The team.

Steve Rhodes brings decades of business, finance, and banking experience to his position at Trendlines.

He serves as the Chair of Trendlines Investments Israel, as Investment Committee Chair of Trendlines Medical Singapore, as Chair of the Trendlines Agrifood Fund and of the Agrifood Innovation Centre (AFIC) based in Singapore. Additionally, Steve is a director and chair of several Trendlines’ portfolio companies.

Steve founded The Trendlines Group with Todd Dollinger in 2007 and shares the positions of Chair and CEO of Trendlines with Todd. Under the strength of their long-term business partnership, Todd and Steve oversaw Trendlines’ IPO on the Singapore Stock Exchange; founded more than 90 companies; raised funds around the world for Trendlines and its portfolio companies; exited portfolio companies to multinational corporations; took portfolio companies public; and expanded the Group’s activities internationally.

Steve received his MBA from the University of Chicago and a B.A. from Harvard University. He is a CPA in the State of Illinois.

Todd Dollinger brings more than four decades of wide-ranging marketing, sales, and entrepreneurial experience to Trendlines.

He chairs the investment committees of Trendlines Investments Israel, our Singapore-based Trendlines Agrifood Innovation Centre, and the Trendlines Agrifood Fund. Additionally, Todd is a director and chairs several Trendlines’ portfolio companies. He also serves as a board member of the non-profit Davos-based AO Foundation’s Technology Board which, inter alia, is responsible for allocating Development Incubator funds.

Todd founded The Trendlines Group with Steve Rhodes in 2007 and shares the positions of Chair and CEO of Trendlines with Steve.

In 1991, Todd joined the marketing department of Israeli medical device start-up SRD Medical Ltd. (“SRD”) and went on to become SRD’s CEO. It was at SRD that Todd and Steve met. In 1993, Todd and Steve founded Trendlines International Ltd. They merged the principal consulting activities of Trendlines International Ltd. into The Trendlines Group in 2008.

Under the strength of their 30-year business partnership, Todd and Steve oversaw Trendlines’ IPO on the Singapore Stock Exchange in 2015; and have raised funds around the world for Trendlines, its venture funds, and portfolio companies. They have exited portfolio companies to multinational corporations; taken portfolio companies public; and have expanded the Group’s activities internationally.

Elka Nir was appointed as our Director on 15 October 2015 and was last re-elected to the Board to serve as our External Director under the Israeli Companies Law on 13 February 2019. She is our Lead Independent Director.

Elka is the founder and CEO of E.LeadIN Ltd., a company that provides business, strategy, marketing, strategic alliances, and investment consultancy services. In addition, she is the CEO of Carmel Ltd. (the economic corporation of Haifa University, Israel), where she is responsible for, among other things, leading commercial and business activities and where she founded and serves as the CEO of Carmel Innovations Ltd., a microfund that invests in projects from Haifa University, Israel. She holds directorships in Carmel Innovations Ltd.’s subsidiaries as well as in several other companies.

She served as the VP marketing, sales, and customer support at a subsidiary of GE Medical before joining General Electric Medical, Israel, as their VP engineering and research. She was the COO and director of development and operations at Biosense Webster (Israel), Ltd., a subsidiary of Johnson & Johnson. She was the managing director and general partner of Giza Venture Capital Fund (“Giza VC Fund”), a venture capital fund that invests in innovative high-tech and life sciences companies and where she was a member of Giza VC Fund’s investment committee and had strong connections to its global investors, specifically in Asia. Elka served as a board director and investment committee member at Van Leer Technology Ventures, a technological incubator that invests in innovative medical and information technology companies.

She received her BSc in computer sciences from the Technion- Israel Institute of Technology and her diploma (magna cum laude) in business administration from the University of Haifa, Israel.

Zeev Bronfeld, together with Chairmen and CEOs Todd Dollinger and Steve Rhodes, founded the Company and was appointed as a Director upon the formation of our Company on 1 May 2007. He was last re-elected on 26 April 2017 in accordance with the Company’s Articles of Association. He is a Non-Executive Director.

Zeev is currently the CEO of M.B.R.T. Development and Investment Ltd. He has significant experience in the management and building of medical device and biotechnology companies. He co-founded Bio-Cell Ltd., an Israeli publicly traded holding company, at the time specializing in biotechnology companies, and was its director and CEO until 25 December 2014 and 11 October 2015, respectively. Zeev is a director and chairman of a number of private and public companies.

He received his BSc in economics from the Hebrew University of Jerusalem.

Boon Ann Sin was appointed as an independent Director on June 22, 2020.

Boon Ann currently serves as a consultant with Drew & Napier. He has more than 30 years of experience working in the legal industry and serving as a director in many listed companies. Skilled in Corporate Law, Corporate Finance, Equity Capital Markets, Mergers and Acquisitions, and Corporate Governance.

Boon Ann has been the deputy managing director of the Corporate & Finance Department at Drew & Napier LLC since 2009, where he is principally engaged in corporate finance and mergers and acquisitions. He was a Member of Parliament for Tampines GRC from 1996 to 2011. During his tenure in Parliament, Sin was a member of the Government Parliamentary Committee for Health and Defense and Foreign Affairs from 2009 to 2011. Prior to his career in politics and private practice, Sin taught Public Law at the Faculty of Law of National University of Singapore from 1987 to 1992.

Boon Ann holds a Master of Laws (LL.M.) from London University and double undergraduate degrees, LL.B and BA, in law and arts from the National University of Singapore.

Nehama Ronen was appointed as an Independent Director on 6 June 2022. She serves as a Non-Executive Director, member of the Audit Committee, Nominating Committee and Remuneration Committees.

Nehama brings over 20 years of experience as a Board member of public companies. In 1996 she was appointed Director General of Israel’s Ministry of Environmental Protection, a post she held until June 1999. Then she served as a member of the Israeli Parliament.

Since 2004, she has held the position of Chair of the Maman Cargo Terminals & Handling Ltd., one of the Israel’s leading logistics and commercial cargo handling company. From 2004 to 2019, Nehama served as the Chair of the ELA Recycling Corporation. Additionally, she served as a director at Bank Hapoalim, Israel’s biggest bank.

Nehama holds a BA in Education and History from Beit Berl College and an MA in Public Administration from Haifa University. She also participated in the Senior Executive Program at the London Business School.

Professor Low Teck Seng was appointed as our Director on 11 August 2022 to serve as our Independent and Non-Executive Director. Professor Low is currently Senior Vice President at the National University of Singapore. He stepped down as CEO of the National Research Foundation, Singapore on 5 August 2022, a position he has held since 2012. He was previously the Managing Director of A*STAR (2010 – 2012) as well as the founding Principal of Republic Polytechnic (2002 -2008) and Dean of the Faculty of Engineering in the National University of Singapore(1998 – 2000).

Prof Low was awarded the National Science and Technology Medal in 2004, the highest honor bestowed on an individual who has made distinguished and exceptional contributions, playing strategic role in the development of Singapore through the promotion and management of R&D. Professor Low has served as a board member of numerous public organizations, including public companies listed on the SGX, namely, Chip Eng Seng Corporation Ltd., ExcelPoint Technologies, Singapore Post Limited and  ISEC Healthcare Ltd.

Prof Low received his BSc in Electrical Engineering and a PhD at the University of Southampton.

Sarit Zeevi was appointed as an Independent and External Director on 31 January 2023.

Sarit is currently the in-house counsel and investments director at Elisha Ltd., a member of the Zeevi Group (a private equity group of companies), where she oversees legal matters and long-term strategy for the group. She leads, among other things, the companies’ strategy and decision making relating to start-up investments, from the selection of targeted companies through due diligence processes and the handling of transactional documents.

Previously, Sarit served as business manager and general counsel at Airtouch Solar Ltd, where she planned and led the company’s fund-raising rounds all the way through to a successful IPO in 2021, managed business strategy as well as performed legal counsel responsibilities while the company was private and later public. She was also in charge of its corporate governance matters. She also served as in-house counsel at Arava Power Company Ltd. where she led a major refinance transaction and handled other regulatory, transactional, and corporate matters.

Additionally, Sarit was a teaching fellow for business English courses at the Faculty of Law of the University of Haifa.

Currently, Sarit serves as an Independent Director, a member of the Oversight Committee and the Remuneration Committee at Blitz Technologies Ltd., a public company listed on the Tel Aviv Stock Exchange and serves as an Independent Director, a member of the Oversight Committee and the Investments Committee at More Mutual Funds (2013) Ltd., a leading Israeli Mutual Funds manager and subsidiary of Y.D. More Investments Ltd., a public company listed on the Tel Aviv Stock Exchange. She also holds directorships in several other private companies.

Sarit holds a Bachelor of Law (cum laude) from the Hebrew University of Jerusalem, and an MBA from Reichman University. She is a member of the Israeli State Bar Association and is licensed to practice law in New York, Texas, and Puerto Rico.